期刊文献+

ULBP3基因转染提高人外周血NK细胞对人成骨肉瘤Saos-2细胞的杀伤活性

ULBP3 gene transfection make Saos-2 cell line more sensitive to human NK killing
下载PDF
导出
摘要 目的 观察ULBP3基因转染对人外周血NK细胞对Saos -2细胞杀伤活性的影响。方法 用RT -PCR方法从人成骨肉瘤组织中提取ULBP3基因 ,构建pcDNA3真核表达质粒 ,以Lipofectamine为载体转染人成骨肉瘤Saos-2细胞 ,用percoll密度梯度离心法分离人外周血NK细胞作为效应细胞 ,以Saos -2细胞和转染ULBP3基因的Saos-2细胞作为靶细胞 ,进行体外杀伤实验 ,比较两组的特异性杀伤率。结果 在效靶比为 3 0∶1时人外周血NK细胞对转染ULBP3基因的Saos-2细胞的特异性杀伤率明显高于对照组。结论 ULBP3基因转染能提高人外周血NK细胞对人成骨肉瘤Saos-2细胞的杀伤活性。 Objective To study the effect of ULBP3 gene transfection on the sensitivity of Saos-2 cell line to human NK killing.Methods The ULBP3 gene fragment obtained by RT-PCR from human osteosarcoma specimen was sequenced and cloned into the pCDNA3 eukaryotic expression vector.Then the recombinant plasmid was transfected into Saos-2 cell line with lipofectamine.With NK cell isolated from human peripheral blood as effect cell,the ULBP3 gene transfected Saos-2 cell and nontransfected Saos-2 cell labelled with 51Cr as target cell,the in vitro NK killing experiment was performed,and the rate of specific lysis was tested.Results The rate of specific lysis of ULBP3 gene transfected Saos-2 cell was much higher than that of nontransfected Saos-2 cell.Conclusion ULBP3 gene transfection make Saos-2 cell line more sensitive to human NK killing.
出处 《中国骨肿瘤骨病》 CAS 2004年第3期167-171,共5页 Chinse Journal Of Bone Tumor And Bone Disease
基金 国家重点基础研究发展规划 (2 0 0 1CB5 10 0 0 7)
关键词 ULBP3 基因转染 外周血NK细胞 成骨肉瘤 SAOS-2 细胞活性 Saos-2 ULBP3 Transfection
  • 相关文献

参考文献8

  • 1[1]Radosavljevic M, Cuillerier B, Wilson MJ,et al. A cluster of ten novel MHC class I related genes on human chromosome 6q24. 2 -q25.3. Genomics, 2002, 79( 1 ) :114 - 123.
  • 2[2]Cosman D, Mullberg J, Sutherland CL, et al. ULBPs, novel MHC class Ⅰ - related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity, 2001,14(2) :123 - 133.
  • 3[3]Andreas Diefenbach, David H. Raulet. The innate immune response to tumors and its role in the induction of T - cell immunity,2002,188:9 -21.
  • 4[4]Diefenbach A, Jensen ER, Jamieson AM,et al. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature,2001, 13 ;413(6852) :165 - 171.
  • 5[5]Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible - 1 gene ( RAE - 1 ) permits natural killer cellmediated rejection of a MHC class Ⅰ - bearing tumor in vivo. Proc Natl Acad Sci U S A, 2001, 25;98(20) :11521 - 11526.
  • 6[6]Vivier E, Tomasello E, Paul P. Lymphocyte activation via NKG2D:towards a new paradigm in immune recognition? Curr Opin Immunol,2002, 14(3) :306 -311.
  • 7[7]Marek Kubin, Linda Cassiano, Jan Chalupny, et al. ULBP1,2,3:novel MHC classⅠ - related molecules that bind to human cytomegalovirus glycoprotein UL16, activate Nk cells. Eur. J. Immunol. 2001,31:1428 - 1437.
  • 8[8]Diefenbach A, Jamieson A M, Liu S D, et al. Ligands for the murine NKG2Drecetor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunol, 2000, 1,119 - 126.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部